共 50 条
- [32] Tumor Necrosis Factor Antagonists Are Superior to Ustekinumab and Vedolizumab for the Prevention of Postoperative Recurrence in Adult Crohn's Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S384 - S384
- [33] Crohn's Disease - Postoperative Recurrence: Adalimumab more effective than Standard Drugs ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (03): : 260 - 260
- [34] Management of postoperative Crohn's disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (04): : 1029 - 1035